Crossbeta Biosciences receives EuroTrans-Bio Grant
Crossbeta Biosciences announced that it has received a Grant of Eur 0.75 million for its lead program in Alzheimer’s Disease. The Grant was awarded by EuroTrans-Bio and allows Crossbeta Biosciences to progress the development of its disease-modifying treatment for Alzheimer’s Disease. This ... more
